|
⚲
|
| Elixir Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001175784 |
| Sale | 2009-05-15 ($25.0 M Offered, $12.0 M Sold) |
| Fund | |
| Phone | 6179957000 |
| Address | 12 Emily Street Cambridge, 02139 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Paul Martha | |
| Peter Distefano | |
| Vaughn Kailian | |
| Ansbert Gadicke | |
| Kenneth Greenberg | |
| Karen Roberts | |
| Robert Kriebel | |
| Dion Madsen | |
| Vernon Cassin |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Poppas Debra E
✚
|
0.0 | |
|
Poppy Care Co
✚
|
0.0 | |
|
Porfido Frank L
✚
|
0.0 | |
|
Port 45, LLC
✚
|
0.0 | |
|
Portable Consultants Inc.
✚
|
0.0 | |
|
Portable, Inc.
✚
|
0.0 | |
|
Port Capital Partners MLP Fund, LP
✚
|
0.0 | |
|
Port Capital Partners Multi Cap Fund, LP
✚
|
0.0 | |
|
Port Capital Small Cap Fund, LP
✚
|
0.0 | |
|
POOL DATA (GIBRALTAR) Ltd
✚
|
0.0 |